How many stem-cell trials for Peripheral Neuropathy are recruiting right now?
As of 2026-08-29: 9 open studies against 50 registrations overall, or 18% of the historical total.
Who these studies will actually take
Studies specify aetiology, require nerve-conduction confirmation and a symptom-score floor, and exclude uncontrolled diabetes. That last exclusion matters: glycaemic control is the intervention with the actual evidence base in diabetic neuropathy.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT02795052 — Neurologic Stem Cell Treatment Study | n/a | Recruiting | 500 | MD Stem Cells | 2016-06 |
| NCT05152368 — Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia | Phase 1 | Recruiting | 20 | The Foundation for Orthopaedics and Regenerative Medicine | 2022-09-09 |
| NCT04684602 — Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions | Phase 1, Phase 2 | Recruiting | 5,000 | Thomas Advanced Medical LLC | 2020-07-09 |
| NCT05735717 — MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | Phase 2 | Recruiting | 70 | Masonic Cancer Center, University of Minnesota | 2023-05-11 |
| NCT07723313 — Effectiveness of Amniotic Membrane Combined With Secretome as an Adjunct to Carpal Tunnel Release Surgery: Evaluation Using the Boston Carpal Tunnel Q | Early Phase 1 | Recruiting | 30 | PT. Prodia Stem Cell Indonesia | 2025-12-15 |
| NCT06625190 — Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors | Phase 1, Phase 2 | Recruiting | 27 | University of Florida | 2026-02-11 |
| NCT00874783 — Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases | n/a | Recruiting | 120 | Hadassah Medical Organization | 2009-04 |
| NCT06328712 — Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-c | Phase 1, Phase 2 | Recruiting | 27 | ENCell | 2024-05-30 |
What recruiting does and does not mean
The status field tracks paperwork, not promise. What matters underneath it is the eligibility list, the outcome measures the sponsor committed to, and whether a site near you is actually enrolling, all of which sit on the registry record itself.
Sites sit in 16 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Jie Shen — 3 registered records
- Cairo University — 2 registered records
- Hope Biosciences Research Foundation — 2 registered records
- ENCell — 2 registered records
- MD Stem Cells — 1 registered record
- Northwestern University — 1 registered record
Frequently asked
How many stem-cell trials for Peripheral Neuropathy are recruiting right now?
9 of 50 registered records (2026-08-29).
Can I join one of these trials?
Only if you meet the published eligibility criteria and the site confirms capacity. Start from the registry record's contact block, not from a clinic advertisement.
Do trials charge participants?
Participants are not usually billed for the study product. A five-figure invoice attached to a supposed trial place means you are buying a treatment, not joining research.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Peripheral Neuropathy: cell-therapy evidence and registered trials
- How much does stem cell therapy for Peripheral Neuropathy cost? (2026)
- Peripheral Neuropathy stem cell therapy — your questions answered (2026)
- Peripheral Neuropathy: cell-therapy evidence by therapy class
- MSC vs PRP for Peripheral Neuropathy: what the registries show